| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_385cd06cfcff26be6ba1f0c5415e5cc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b503b22ece136fdc603ca7dd23c915b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70d6ab1d44ff37a542710aa5efe86f77 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-412 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-0241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73 |
| filingDate |
2008-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4329e3f3eab46dcc1464ae043a2fc50f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85b6c71f63e046f6880b93e0c2403f09 |
| publicationDate |
2016-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9433805-B2 |
| titleOfInvention |
Method for dermal regeneration by administering an ether cross-linked glucomannan/hyaluronic acid composition |
| abstract |
The present invention relates to glucommannan oligosaccharides and polysaccharides that possess one or more properties selected from skin regeneration, wound healing and skin augmentation. More particularly, the invention relates to the use of glucomannan oligosaccharides and polysaccharides for one or more of skin regeneration, wound healing and skin augmentation agents in a mammal. The invention also relates to a pharmaceutical formulation for treating skin of a subject comprising an active component comprising glucomannan in a suitable diluent, excipient or physical form such as dermal scaffold or sponge, the active component being capable of promoting an accumulation of fibroblasts in the skin and stimulating production of collagen in the skin. |
| priorityDate |
2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |